UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 559

Sortiert nach

Scenarios and Economic Analysis of Fronthaul in 5G Optical Networks

Journal of lightwave technology, 2019-01, Vol.37 (2), p.585-591

2019

Link zum Volltext
IEEE_Xplore

Machine Learning for Optical Network Security Monitoring: A Practical Perspective

Journal of lightwave technology, 2020-06, Vol.38 (11), p.2860-2871

2020

Link zum Volltext
IEEE_Xplore

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.29-42

2023

Link zum Volltext

Verfügbarkeit prüfen

Xhaul: toward an integrated fronthaul/backhaul architecture in 5G networks

IEEE wireless communications, 2015-10, Vol.22 (5), p.32-40

2015

Link zum Volltext
IEEE_Xplore

Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach

European journal of cancer (1990), 2021-01, Vol.143, p.75-77

2021

Link zum Volltext

Verfügbarkeit prüfen

Optical network security management: requirements, architecture, and efficient machine learning models for detection of evolving threats [Invited]

Journal of optical communications and networking, 2021-02, Vol.13 (2), p.A144-A155

2021

Link zum Volltext
IEEE_Xplore

STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?

European journal of cancer (1990), 2021-11, Vol.157, p.108-113

2021

Link zum Volltext

Verfügbarkeit prüfen

The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)

Current oncology reports, 2021-11, Vol.23 (11), p.126-126, Article 126

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Targeted oncology, 2022, Vol.17 (1), p.43-51

2022

Link zum Volltext

Verfügbarkeit prüfen

Root Cause Analysis for Autonomous Optical Network Security Management

IEEE eTransactions on network and service management, 2022-09, Vol.19 (3), p.2702-2713

2022

Link zum Volltext
IEEE_Xplore

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1177-1187

2020

Link zum Volltext

Verfügbarkeit prüfen

5G-Crosshaul: An SDN/NFV Integrated Fronthaul/Backhaul Transport Network Architecture

IEEE wireless communications, 2017-02, Vol.24 (1), p.38-45

2017

Link zum Volltext
IEEE_Xplore

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2738-2745

2019

Link zum Volltext

Verfügbarkeit prüfen

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

Therapeutic Advances in Respiratory Disease, 2018-01, Vol.12, p.1753466618808659-1753466618808659

2018

Link zum Volltext

Verfügbarkeit prüfen

E-MDAV: A Framework for Developing Data-Intensive Web Applications

Informatics (Basel), 2022-03, Vol.9 (1), p.12

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies

Immunotherapy, 2022-11, Vol.14 (16), p.1329-1340

2022

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

Translational lung cancer research, 2023-11, Vol.12 (11), p.2322-2329

2023

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

Therapeutic Advances in Medical Oncology, 2017-06, Vol.9 (6), p.387-404

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e001636

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review

Lung cancer (Auckland), 2023-01, Vol.14, p.11-25

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10292

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors

International journal of molecular sciences, 2020-11, Vol.21 (23), p.9056

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(447)
Mit Volltextzugriff
(523)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Scenarios and Economic Analysis of Fronthaul in 5G Optical Networks

Machine Learning for Optical Network Security Monitoring: A Practical Perspective

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

Xhaul: toward an integrated fronthaul/backhaul architecture in 5G networks

Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach

Optical network security management: requirements, architecture, and efficient machine learning models for detection of evolving threats [Invited]

STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?

The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)

Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma

Root Cause Analysis for Autonomous Optical Network Security Management

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

5G-Crosshaul: An SDN/NFV Integrated Fronthaul/Backhaul Transport Network Architecture

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

E-MDAV: A Framework for Developing Data-Intensive Web Applications

Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma

Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies

Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors

Suchergebnisse filtern